NKGen Biotech, Inc.
NKGN
$0.06
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 70.56% | 46.61% | 13.89% | -196.03% | -180.56% |
| Total Depreciation and Amortization | 11.67% | 9.31% | 6.20% | 3.90% | 1.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -95.22% | -64.02% | -37.62% | 772.99% | 929.40% |
| Change in Net Operating Assets | -100.35% | -38.27% | 369.24% | 1,215.07% | 754.44% |
| Cash from Operations | 6.74% | 4.86% | -1.91% | -1.15% | 2.54% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -185.71% | 0.00% | -16.28% | 49.23% | 43.09% |
| Cash from Investing | -- | 72.92% | 57.14% | 102.86% | 100.00% |
| Total Debt Issued | -20.55% | -34.49% | -60.66% | -6.38% | 0.13% |
| Total Debt Repaid | -1,479.53% | -904.00% | -- | -- | 33.77% |
| Issuance of Common Stock | 211.04% | 105.77% | -79.17% | 936.02% | 954.09% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 115.95% | 153.10% | 138.23% | -95.32% | -- |
| Cash from Financing | -5.40% | -5.88% | -58.98% | -9.28% | -6.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 45.04% | -125.79% | -198.32% | -202.51% | -217.77% |